Genomics of Fibromuscular Dysplasia
- PMID: 29883369
- PMCID: PMC5983654
- DOI: 10.3390/ijms19051526
Genomics of Fibromuscular Dysplasia
Abstract
Fibromuscular Dysplasia (FMD) is “an idiopathic, segmental, non-atherosclerotic and non-inflammatory disease of the musculature of arterial walls, leading to stenosis of small and medium-sized arteries” (Persu, et al; 2014). FMD can lead to hypertension, arterial dissections, subarachnoid haemorrhage, stroke or mesenteric ischemia. The pathophysiology of the disease remains elusive. While familial cases are rare (<5%) in contemporary FMD registries, there is evidence in favour of the existence of multiple genetic factors involved in this vascular disease. Recent collaborative efforts allowed the identification of a first genetic locus associated with FMD. This intronic variant located in the phosphatase and actin regulator 1 gene (PHACTR1) may influence the transcription activity of the endothelin-1 gene (EDN1) located nearby on chromosome 6. Interestingly, the PHACTR1 locus has also been involved in vascular hypertrophy in normal subjects, carotid dissection, migraine and coronary artery disease. National and international registries of FMD patients, with deep and harmonised phenotypic and genetic characterisation, are expected to be instrumental to improve our understanding of the genetic basis and pathophysiology of this intriguing vascular disease.
Keywords: PHACTR1; cervical artery dissection; fibromuscular dysplasia; genetic association; non atherosclerotic vascular stenosis; spontaneous coronary arteries dissection.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Olin J.W., Froehlich J., Gu X., Bacharach J.M., Eagle K., Gray B.H., Jaff M.R., Kim E.S., Mace P., Matsumoto A.H., et al. The United States registry for fibromuscular dysplasia: Results in the first 447 patients. Circulation. 2012;125:3182–3190. doi: 10.1161/CIRCULATIONAHA.112.091223. - DOI - PubMed
-
- Plouin P.-F., Baguet J.-P., Thony F., Ormezzano O., Azarine A., Silhol F., Oppenheim C., Bouhanick B., Boyer L., Persu A., et al. High prevalence of multiple arterial bed lesions in patients with fibromuscular dysplasia: The ARCADIA registry (Assessment of Renal and Cervical Artery Dysplasia) Hypertension. 2017;70:652–658. doi: 10.1161/HYPERTENSIONAHA.117.09539. - DOI - PubMed
-
- Olin J.W., Gornik H.L., Bacharach J.M., Biller J., Fine L.J., Gray B.H., Gray W.A., Gupta R., Hamburg N.M., Katzen B.T., et al. Fibromuscular dysplasia: State of the science and critical unanswered questions: A scientific statement from the American Heart Association. Circulation. 2014;129:1048–1078. doi: 10.1161/01.cir.0000442577.96802.8c. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
